Brought to you by:
Bryan Kay
Cook Medical issues Class I recall for Beacon Tip angiographic catheters
Cook Medical has initiated a Class I recall of its Beacon Tip 5F angiographic catheter. This follows reports of tip separation that could result in serious injury or death. The recall, identified as the most serious type by the Food…
StentIt launches first-in-human trial of bioresorbable stent to treat below-the-knee CLTI
StentIt has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischemia (CLTI) below the knee have successfully been treated using the RFS implant. In this clinical procedure,…
Vivasure Medical submits premarket approval to FDA for PerQseal Elite closure system
Vivasure Medical has announced the submission of a premarket approval application to the Food and Drug Administration (FDA) for its PerQseal Elite vascular closure system for arterial procedures. In a recent press release the company has stated that the submission…
Gore Tag thoracic branch endoprosthesis receives expanded FDA approval for endovascular aortic arch repair
Gore has announced that the Gore Tag thoracic branch endoprosthesis (TBE) is now approved by the Food and Drug Administration (FDA) for use in Zones 0 and 1, expanding its indication for the endovascular repair of lesions in the aortic…
Penumbra’s STORM-PE randomized trial completes enrollment
Penumbra has announced the completion of enrollment in the STORM-PE clinical trial. The pivotal, prospective, multicenter randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash plus anticoagulation versus anticoagulation alone for the treatment…
Aventus thrombectomy system gains FDA clearance for PE treatment
Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded indication to treat pulmonary embolism (PE). The Aventus System is a next-generation mechanical thrombectomy platform developed…
The people and devices that put ‘the vascular in vascular’
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today will form the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at VAM 2025. Jerry Goldstone, MD, an…
Vascular surgery maintains popularity, becomes ‘more competitive’ after switch to virtual interviews
A study aimed at assessing the impact of a pandemic-related switch to virtual recruitment from in-person interviews on the Match for vascular surgery residents demonstrated that the transition had no impact on the popularity of the specialty. This is among…
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in South Asia, attendees of the International Chapter Education Session at VAM 2025 heard yesterday morning. That…
Acellular tissue engineered vessel outperforms AVF in high-risk hemodialysis patients
Results from the CLN-PRO-V007 randomized controlled trial of Humacyte’s acellular tissue engineered vessel (ATEV) are set to be shared today during VAM 2025 Plenary 6 (10–11 a.m., First Floor, Great Hall A), showing several clinical benefits when compared to arteriovenous…